{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:04:54Z","timestamp":1793747094332,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Ministry of Health & Welfare, Republic of Korea","award":["RS-2021-KH119931"],"award-info":[{"award-number":["RS-2021-KH119931"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35628-w","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:34:44Z","timestamp":1768584884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient-reported health utility of stroke and gastrointestinal bleeding related to DOACs in atrial fibrillation: a vignette-based substudy of a randomized controlled trial"],"prefix":"10.1038","volume":"16","author":[{"given":"Sun-Hong","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo-Jeong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Hyun","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soonil","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So-Ryoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eue-Keun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eui-Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"35628_CR1","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0140-6736(20)32439-9","volume":"396","author":"N Chan","year":"2020","unstructured":"Chan, N., Sobieraj-Teague, M. & Eikelboom, J. W. Direct oral anticoagulants: evidence and unresolved issues. Lancet 396, 1767\u20131776. https:\/\/doi.org\/10.1016\/S0140-6736(20)32439-9 (2020).","journal-title":"Lancet"},{"key":"35628_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2147\/CLEP.S290707","volume":"13","author":"A Gabet","year":"2021","unstructured":"Gabet, A. et al. Stroke incidence and death in atrial fibrillation patients newly treated with direct oral anticoagulants. Clin. Epidemiol. 13, 131\u2013140. https:\/\/doi.org\/10.2147\/CLEP.S290707 (2021).","journal-title":"Clin. Epidemiol."},{"key":"35628_CR3","doi-asserted-by":"publisher","unstructured":"Hindricks, G. et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC (vol 42, pg 373, 2021). European Heart Journal 42, 4194\u20134194, (2020). https:\/\/doi.org\/10.1093\/eurheartj\/ehab648 (2021).","DOI":"10.1093\/eurheartj\/ehab648"},{"key":"35628_CR4","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1001\/jama.2018.17242","volume":"320","author":"WA Ray","year":"2018","unstructured":"Ray, W. A. et al. Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper Gastrointestinal tract bleeding. JAMA 320, 2221\u20132230. https:\/\/doi.org\/10.1001\/jama.2018.17242 (2018).","journal-title":"JAMA"},{"key":"35628_CR5","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1136\/heartjnl-2021-319332","volume":"108","author":"J Komen","year":"2022","unstructured":"Komen, J. et al. Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and Gastrointestinal bleeds. Heart 108, 613\u2013618. https:\/\/doi.org\/10.1136\/heartjnl-2021-319332 (2022).","journal-title":"Heart"},{"key":"35628_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12955-020-01388-y","volume":"18","author":"PN Kariyawasam","year":"2020","unstructured":"Kariyawasam, P. N., Pathirana, K. D. & Hewage, D. C. Factors associated with health related quality of life of patients with stroke in Sri Lankan context. Health Qual. Life Outcomes. 18, 129. https:\/\/doi.org\/10.1186\/s12955-020-01388-y (2020).","journal-title":"Health Qual. Life Outcomes"},{"key":"35628_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-14-92","volume":"14","author":"M Baumann","year":"2014","unstructured":"Baumann, M., Le Bihan, E., Chau, K. & Chau, N. Associations between quality of life and socioeconomic factors, functional impairments and dissatisfaction with received information and home-care services among survivors living at home two years after stroke onset. BMC Neurol. 14, 1\u201312 (2014).","journal-title":"BMC Neurol."},{"key":"35628_CR8","doi-asserted-by":"publisher","unstructured":"Son, Y. J., Baek, K. H., Lee, S. J. & Seo, E. J. Health-Related quality of life and associated factors in patients with atrial fibrillation: an integrative literature review. Int. J. Environ. Res. Public. Health. 16 https:\/\/doi.org\/10.3390\/ijerph16173042 (2019).","DOI":"10.3390\/ijerph16173042"},{"key":"35628_CR9","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1055\/s-0041-1730035","volume":"5","author":"P Zappulla","year":"2021","unstructured":"Zappulla, P. & Calvi, V. Gastrointestinal bleeding and direct oral anticoagulants among patients with atrial fibrillation: Risk, Prevention, Management, and quality of life. TH. Open. 5, e200\u2013e210. https:\/\/doi.org\/10.1055\/s-0041-1730035 (2021).","journal-title":"TH. Open."},{"key":"35628_CR10","doi-asserted-by":"publisher","first-page":"e007230","DOI":"10.1136\/bmjopen-2014-007230","volume":"5","author":"HE Campbell","year":"2015","unstructured":"Campbell, H. E. et al. Costs and quality of life associated with acute upper Gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial. BMJ Open. 5, e007230. https:\/\/doi.org\/10.1136\/bmjopen-2014-007230 (2015).","journal-title":"BMJ Open."},{"key":"35628_CR11","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1161\/STROKEAHA.111.000402","volume":"44","author":"AR Harrington","year":"2013","unstructured":"Harrington, A. R., Armstrong, E. P., Nolan, P. E. Jr. & Malone, D. C. Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation. Stroke 44, 1676\u20131681. https:\/\/doi.org\/10.1161\/STROKEAHA.111.000402 (2013).","journal-title":"Stroke"},{"key":"35628_CR12","doi-asserted-by":"publisher","first-page":"238146831986682","DOI":"10.1177\/2381468319866828","volume":"4","author":"HHZ Thom","year":"2019","unstructured":"Thom, H. H. Z. et al. Directly acting oral anticoagulants for the prevention of stroke in atrial fibrillation in England and wales: Cost-Effectiveness model and value of information analysis. MDM Policy Pract. 4, 2381468319866828. https:\/\/doi.org\/10.1177\/2381468319866828 (2019).","journal-title":"MDM Policy Pract."},{"key":"35628_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.jval.2020.12.017","volume":"24","author":"LS Matza","year":"2021","unstructured":"Matza, L. S., Stewart, K. D., Lloyd, A. J., Rowen, D. & Brazier, J. E. Vignette-Based utilities: Usefulness, Limitations, and methodological recommendations. Value Health. 24, 812\u2013821. https:\/\/doi.org\/10.1016\/j.jval.2020.12.017 (2021).","journal-title":"Value Health"},{"key":"35628_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1017\/s000305540400108x","volume":"98","author":"G King","year":"2004","unstructured":"King, G., Murray, C. J. L., Salomon, J. A. & Tandon, A. Enhancing the validity and Cross-Cultural comparability of measurement in survey research. Am. Polit Sci. Rev. 98, 191\u2013207. https:\/\/doi.org\/10.1017\/s000305540400108x (2004).","journal-title":"Am. Polit Sci. Rev."},{"key":"35628_CR15","unstructured":"Gastrointestinal protection Using proton-pump inhibitor in pAtients who RequireD Oral AntiCoagulatns - randomized clinical trial: Study details, (2021). https:\/\/cris.nih.go.kr\/cris\/search\/detailSearch.do?seq=20648&search_page=L"},{"key":"35628_CR16","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","volume":"20","author":"M Herdman","year":"2011","unstructured":"Herdman, M. et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual. Life Res. 20, 1727\u20131736. https:\/\/doi.org\/10.1007\/s11136-011-9903-x (2011).","journal-title":"Qual. Life Res."},{"key":"35628_CR17","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s11136-012-0322-4","volume":"22","author":"MF Janssen","year":"2013","unstructured":"Janssen, M. F. et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual. Life Res. 22, 1717\u20131727. https:\/\/doi.org\/10.1007\/s11136-012-0322-4 (2013).","journal-title":"Qual. Life Res."},{"key":"35628_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40258-017-0310-5","volume":"15","author":"NJ Devlin","year":"2017","unstructured":"Devlin, N. J. & Brooks, R. EQ-5D and the EuroQol group: Past, present and future. Appl. Health Econ. Health Policy. 15, 127\u2013137. https:\/\/doi.org\/10.1007\/s40258-017-0310-5 (2017).","journal-title":"Appl. Health Econ. Health Policy"},{"key":"35628_CR19","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s11136-015-1205-2","volume":"25","author":"SH Kim","year":"2016","unstructured":"Kim, S. H. et al. The EQ-5D-5L valuation study in Korea. Qual. Life Res. 25, 1845\u20131852. https:\/\/doi.org\/10.1007\/s11136-015-1205-2 (2016).","journal-title":"Qual. Life Res."},{"key":"35628_CR20","doi-asserted-by":"publisher","first-page":"e0226730","DOI":"10.1371\/journal.pone.0226730","volume":"14","author":"F Witassek","year":"2019","unstructured":"Witassek, F. et al. Health-related quality of life in patients with atrial fibrillation: the role of symptoms, comorbidities, and the type of atrial fibrillation. PLoS One. 14, e0226730. https:\/\/doi.org\/10.1371\/journal.pone.0226730 (2019).","journal-title":"PLoS One"},{"key":"35628_CR21","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s11136-019-02171-3","volume":"28","author":"V Srinonprasert","year":"2019","unstructured":"Srinonprasert, V. et al. Factors associated with low health-related quality of life among younger and older Thai patients with non-valvular atrial fibrillation. Qual. Life Res. 28, 2091\u20132098. https:\/\/doi.org\/10.1007\/s11136-019-02171-3 (2019).","journal-title":"Qual. Life Res."},{"key":"35628_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ahj.2016.08.003","volume":"182","author":"TC Randolph","year":"2016","unstructured":"Randolph, T. C. et al. Patient factors associated with quality of life in atrial fibrillation. Am. Heart J. 182, 135\u2013143. https:\/\/doi.org\/10.1016\/j.ahj.2016.08.003 (2016).","journal-title":"Am. Heart J."},{"key":"35628_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11136-010-9591-y","volume":"19","author":"J Berg","year":"2010","unstructured":"Berg, J., Lindgren, P., Nieuwlaat, R., Bouin, O. & Crijns, H. Factors determining utility measured with the EQ-5D in patients with atrial fibrillation. Qual. Life Res. 19, 381\u2013390. https:\/\/doi.org\/10.1007\/s11136-010-9591-y (2010).","journal-title":"Qual. Life Res."},{"key":"35628_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jacc.2003.08.037","volume":"43","author":"VE Hagens","year":"2004","unstructured":"Hagens, V. E. et al. Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the rate control versus electrical cardioversion (RACE) study. J. Am. Coll. Cardiol. 43, 241\u2013247. https:\/\/doi.org\/10.1016\/j.jacc.2003.08.037 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"35628_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1177\/2047487314538855","volume":"22","author":"L Zhang","year":"2015","unstructured":"Zhang, L., Gallagher, R. & Neubeck, L. Health-related quality of life in atrial fibrillation patients over 65 years: A review. Eur. J. Prev. Cardiol. 22, 987\u20131002. https:\/\/doi.org\/10.1177\/2047487314538855 (2015).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"35628_CR26","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.numecd.2020.07.009","volume":"30","author":"DA Koutoukidis","year":"2020","unstructured":"Koutoukidis, D. A., Jones, N. R., Taylor, C. J., Casadei, B. & Aveyard, P. Obesity, self-reported symptom severity, and quality of life in people with atrial fibrillation: A community-based cross-sectional survey. Nutr. Metab. Cardiovasc. Dis. 30, 2221\u20132229. https:\/\/doi.org\/10.1016\/j.numecd.2020.07.009 (2020).","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"35628_CR27","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1378\/chest.10-0134","volume":"138","author":"R Pisters","year":"2010","unstructured":"Pisters, R. et al. A novel User-Friendly score (HAS-BLED) to assess 1-Year risk of major bleeding in patients with atrial fibrillation. Chest 138, 1093\u20131100. https:\/\/doi.org\/10.1378\/chest.10-0134 (2010).","journal-title":"Chest"},{"key":"35628_CR28","unstructured":"Yang, D.-W., Cho, B.-l., Chey, J.-Y., Kim, S.-Y. & Kim, B.-S. The development and validation of Korean dementia screening questionnaire (KDSQ). J. Korean Neurol. Assoc. 20, 135\u2013141 (2002)."},{"key":"35628_CR29","doi-asserted-by":"publisher","first-page":"17301","DOI":"10.1038\/srep17301","volume":"5","author":"CW Pan","year":"2015","unstructured":"Pan, C. W. et al. Cognitive dysfunction and health-related quality of life among older Chinese. Sci. Rep. 5, 17301. https:\/\/doi.org\/10.1038\/srep17301 (2015).","journal-title":"Sci. Rep."},{"key":"35628_CR30","doi-asserted-by":"publisher","first-page":"110353","DOI":"10.1016\/j.jpsychores.2020.110353","volume":"142","author":"M Sadlonova","year":"2021","unstructured":"Sadlonova, M. et al. Health-related quality of life, anxiety and depression up to 12 months post-stroke: influence of sex, age, stroke severity and atrial fibrillation\u2013A longitudinal subanalysis of the Find-AFRANDOMISED trial. J. Psychosom. Res. 142, 110353 (2021).","journal-title":"J. Psychosom. Res."},{"key":"35628_CR31","doi-asserted-by":"publisher","first-page":"e024296","DOI":"10.1161\/JAHA.121.024296","volume":"11","author":"RA Joundi","year":"2022","unstructured":"Joundi, R. A. et al. Health state utility values in people with stroke: A systematic review and Meta-Analysis. J. Am. Heart Assoc. 11, e024296. https:\/\/doi.org\/10.1161\/JAHA.121.024296 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"35628_CR32","doi-asserted-by":"publisher","first-page":"e007559","DOI":"10.1161\/JAHA.117.007559","volume":"7","author":"RB Schnabel","year":"2018","unstructured":"Schnabel, R. B. et al. Symptom burden of atrial fibrillation and its relation to interventions and outcome in Europe. J. Am. Heart Assoc. 7, e007559. https:\/\/doi.org\/10.1161\/JAHA.117.007559 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"35628_CR33","doi-asserted-by":"publisher","first-page":"100062","DOI":"10.1016\/j.pecinn.2022.100062","volume":"1","author":"C Yao","year":"2022","unstructured":"Yao, C., Jones, A. E., Slager, S., Fagerlin, A. & Witt, D. M. Exploring clinician perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapy. PEC Innov. 1, 100062. https:\/\/doi.org\/10.1016\/j.pecinn.2022.100062 (2022).","journal-title":"PEC Innov."},{"key":"35628_CR34","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/eurjcn\/zvad094","volume":"23","author":"I Ueda","year":"2023","unstructured":"Ueda, I. et al. Patient concern regarding bleeding side effects from oral anticoagulation therapy for atrial fibrillation: an analysis from the multicentre KiCS-AF registry. Eur. J. Cardiovasc. Nurs. 23, 358\u2013366. https:\/\/doi.org\/10.1093\/eurjcn\/zvad094 (2023).","journal-title":"Eur. J. Cardiovasc. Nurs."},{"key":"35628_CR35","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.jacc.2020.04.053","volume":"76","author":"GF Tomaselli","year":"2020","unstructured":"Tomaselli, G. F. et al. 2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American college of cardiology solution set oversight committee. J. Am. Coll. Cardiol. 76, 594\u2013622 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"35628_CR36","doi-asserted-by":"crossref","unstructured":"Romiti, G. F. & Lip, G. Y. Switching Anticoagulants and Managing Complexity in Frail Patients With Atrial Fibrillation: An Integrated Approach. J. Am. Coll. Cardiol. 86, 440\u2013443 (2025).","DOI":"10.1016\/j.jacc.2025.06.020"},{"key":"35628_CR37","doi-asserted-by":"publisher","unstructured":"Bucci, T. et al. Adverse events in clinically complex elderly patients with atrial fibrillation according to oral anticoagulation status. EClinicalMedicine 78, 102974. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102974 (2024).","DOI":"10.1016\/j.eclinm.2024.102974"},{"key":"35628_CR38","doi-asserted-by":"publisher","unstructured":"Joglar, J. A. et al. 2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Col. Cardiol. 83, 109\u2013279. https:\/\/doi.org\/10.1016\/j.jacc.2023.08.017 (2024).","DOI":"10.1016\/j.jacc.2023.08.017"},{"key":"35628_CR39","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/s0735-1097(00)00886-x","volume":"36","author":"P Dorian","year":"2000","unstructured":"Dorian, P. et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J. Am. Coll. Cardiol. 36, 1303\u20131309. https:\/\/doi.org\/10.1016\/s0735-1097(00)00886-x (2000).","journal-title":"J. Am. Coll. Cardiol."},{"key":"35628_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1161\/CIRCOUTCOMES.114.001303","volume":"8","author":"JV Freeman","year":"2015","unstructured":"Freeman, J. V. et al. Association between atrial fibrillation Symptoms, quality of Life, and patient outcomes: results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF). Circ. Cardiovasc. Qual. Outcomes. 8, 393\u2013402. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.114.001303 (2015).","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"35628_CR41","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1001\/jamacardio.2016.0529","volume":"1","author":"JP Piccini","year":"2016","unstructured":"Piccini, J. P. et al. Differences in clinical and functional outcomes of atrial fibrillation in women and men. JAMA Cardiol. 1, 282\u2013291. https:\/\/doi.org\/10.1001\/jamacardio.2016.0529 (2016).","journal-title":"JAMA Cardiol."},{"key":"35628_CR42","doi-asserted-by":"publisher","unstructured":"Blum, S. et al. Prospective assessment of Sex-Related differences in symptom status and health perception among patients with atrial fibrillation. J. Am. Heart Assoc. 6 https:\/\/doi.org\/10.1161\/JAHA.116.005401 (2017).","DOI":"10.1161\/JAHA.116.005401"},{"key":"35628_CR43","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1093\/europace\/euaa210","volume":"22","author":"TS Potpara","year":"2020","unstructured":"Potpara, T. S. et al. Self-reported treatment burden in patients with atrial fibrillation: quantification, major determinants, and implications for integrated holistic management of the arrhythmia. Europace 22, 1788\u20131797. https:\/\/doi.org\/10.1093\/europace\/euaa210 (2020).","journal-title":"Europace"},{"key":"35628_CR44","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/1477-7525-9-91","volume":"9","author":"Q Almeida Gde","year":"2011","unstructured":"Almeida Gde, Q., Noblat Lde, A. & Passos, L. C. Do Nascimento, H. F. Quality of life analysis of patients in chronic use of oral anticoagulant: an observational study. Health Qual. Life Outcomes. 9, 91. https:\/\/doi.org\/10.1186\/1477-7525-9-91 (2011).","journal-title":"Health Qual. Life Outcomes"},{"key":"35628_CR45","first-page":"393","volume":"8","author":"JV Freeman","year":"2015","unstructured":"Freeman, J. V. et al. Association between atrial fibrillation symptoms, quality of life, and patient outcomes: results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF). Circulation: Cardiovasc. Qual. Outcomes. 8, 393\u2013402 (2015).","journal-title":"Circulation: Cardiovasc. Qual. Outcomes"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35628-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35628-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35628-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T09:33:48Z","timestamp":1770370428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35628-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35628"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35628-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Eue-Keun Choi reported research grants or speaking fees from Bayer, BMS\/Pfizer, Biosense Webster, Chong Kun Dang, Daiichi-Sankyo, Dreamtech Co., Ltd., Medtronic, Samjinpharm, Sanofi-Aventis, Seers Technology, Skylabs, and Yuhan. The other authors have no financial conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5328"}}